Minimum important difference (MID) is crucial in sample size estimation and interpretation of trial results
This is a poster presented at the 6th International Clinical Trials Methodology Conference (ICTMC 2022).
It summarises work conducted to elicit minimum important differences in DEMQOL and DEMQOL-U, two dementia specific quality of life outcome measures.
Journal article: https://doi.org/10.1007/s11136-021-02900-7
The data was from Journeying through Dementia Trial, funded by the NIHR Health Technology Assessment Programme (project number 14/140/80).
ISRCTN17993825 on 11th October 2016
- There is no personal data or any that requires ethical approval
- The data complies with the institution and funders' policies on access and sharing
Sharing and access restrictions
- The data can be shared openly
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files